Nashville, TX26 Active Studies

Ankylosing Spondylitis Clinical Trials in Nashville, TX

Find 26 actively recruiting ankylosing spondylitis clinical trials in Nashville, TX. Connect with local research sites and explore new treatment options.

26
Active Trials
25
Sponsors
23,548
Enrolling

Recruiting Ankylosing Spondylitis Studies in Nashville

About Ankylosing Spondylitis Clinical Trials in Nashville

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 26 ankylosing spondylitis clinical trials recruiting participants in Nashville, TX. These studies are seeking a combined 23,548 participants. Research is being sponsored by Boston Children's Hospital, VB Spine, LLC, University College, London and 22 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Nashville — FAQ

Are there ankylosing spondylitis clinical trials in Nashville?

Yes, there are 26 ankylosing spondylitis clinical trials currently recruiting in Nashville, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 26 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 13, 2026 from ClinicalTrials.gov